Amicar Tablet Generic Gets FDA Approval
Aminocaprioc Acid Tablets are useful in enhancing hemostasis when fibrinolysis contributes to bleeding. The fibrinolysis-inhibitory effects of aminocaproic acid appear to be exerted principally via inhibition of plasminogen activators and to a lesser degree through antiplasmin activity. In life-threatening situations, transfusion of appropriate blood products and other emergency measures may be required.
Aminocaproic Acid Tablets will be available in 500mg and 1000mg strengths.
For more information visit vitruvias.com.